Literature DB >> 7905733

L-trans-pyrrolidine-2,4-dicarboxylate and cis-1-aminocyclobutane-1,3-dicarboxylate behave as transportable, competitive inhibitors of the high-affinity glutamate transporters.

R Griffiths1, J Dunlop, A Gorman, J Senior, A Grieve.   

Abstract

The ability of two conformationally restricted analogues of L-glutamate to function as non-transportable inhibitors of plasma membrane L-glutamate transport was investigated in primary cultures of cerebellar granule cells and cortical astrocytes. L-trans-Pyrrolidine-2,4-dicarboxylic acid (L-trans-PDC) and cis-1-aminocyclobutane-1,3-dicarboxylic acid (cis-ACBD) behaved as linear competitive inhibitors of the uptake of D-[3H]aspartate (used as a non-metabolizable analogue of L-glutamate) exhibiting Ki values between 40 and 145 microM; L-trans-PDC being the more potent inhibitor in each preparation. However, both L-trans-PDC and cis-ACBD, over a concentration range of 1 microM-5 mM, dose-dependently stimulated the release of exogenously supplied D-[3H]aspartate from granule cells maintained in a continuous superfusion system. The stimulated release was independent of extracellular calcium ions; essentially superimposable dose-response profiles being obtained in the absence and presence of 1.3 mM CaCl2 and yielding EC50 values of 16-25 microM and 180-220 microM for L-trans-PDC and cis-ACBD, respectively. Stimulated release of D-[3H]aspartate was unaffected by either 300 microM D-(-)-2-amino-5-phosphonopentanoic acid [D-APV; a selective antagonist of the N-methyl-D-aspartate (NMDA) receptor] or by 25 microM 6-cyano-7-nitroquinoxaline-2,3-dione [CNQX; a selective antagonist of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptor]. The release of D-[3H]-aspartate following stimulation by either L-trans-PDC or cis-ACBD was however markedly attenuated following substitution in the superfusion medium of sodium ions by choline ions. Taken together, these results support an action of L-trans-PDC and cis-ACBD consistent with that of being competitive substrates rather than non-transportable blockers of the plasma membrane L-glutamate uptake system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7905733     DOI: 10.1016/0006-2952(94)90016-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  14 in total

1.  Activity-dependent recruitment of extrasynaptic NMDA receptor activation at an AMPA receptor-only synapse.

Authors:  Beverley A Clark; Stuart G Cull-Candy
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

2.  Glia mechanisms in mood regulation: a novel model of mood disorders.

Authors:  Younglim Lee; Denise Gaskins; Amit Anand; Anantha Shekhar
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

3.  On the significance of perfusion rate in the study of glutamate release from superfused synaptosomes.

Authors:  K J Collard
Journal:  Neurochem Res       Date:  1996-03       Impact factor: 3.996

Review 4.  Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.

Authors:  Kou Takahashi; Joshua B Foster; Chien-Liang Glenn Lin
Journal:  Cell Mol Life Sci       Date:  2015-06-02       Impact factor: 9.261

5.  Acute decrease in net glutamate uptake during energy deprivation.

Authors:  D Jabaudon; M Scanziani; B H Gähwiler; U Gerber
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

6.  Changes in extracellular acid-base homeostasis in cerebral ischemia.

Authors:  D L Taylor; T P Obrenovitch; L Symon
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

7.  Glutamate uptake limits synaptic excitation of retinal ganglion cells.

Authors:  M H Higgs; P D Lukasiewicz
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

8.  Functional roles of high-affinity glutamate transporters in cochlear afferent synaptic transmission in the mouse.

Authors:  Zhiqiang Chen; Sharon G Kujawa; William F Sewell
Journal:  J Neurophysiol       Date:  2010-03-10       Impact factor: 2.714

9.  WAY-855 (3-amino-tricyclo[2.2.1.02.6]heptane-1,3-dicarboxylic acid): a novel, EAAT2-preferring, nonsubstrate inhibitor of high-affinity glutamate uptake.

Authors:  John Dunlop; Scott Eliasof; Gary Stack; H Beal McIlvain; Alexander Greenfield; Dianne Kowal; Robert Petroski; Tikva Carrick
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

10.  Differences in the release of L-glutamate and D-aspartate from primary neuronal chick cultures.

Authors:  L Lewin; M O Mattsson; A Sellström
Journal:  Neurochem Res       Date:  1996-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.